HopeStage
Back to all studies
CompletedNCT02192931

Creatine Compared With Placebo for Women Using Methamphetamine

About this titleRead the official source — NCT02192931
Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
Salt Lake CitySee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2014
Recruitment status
Completed
Enrollment listed in the registry
65
Sponsor
Perry Renshaw
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT02192931
Official title
Show the full official title

A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Perry Renshaw.

Did this study involve medication?

Yes. The study involved medication, including Creatine monohydrate.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies